Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  TEL AVIV STOCK EXCHANGE  >  Teva Pharmaceutical Industries Limited    TEVA   IL0006290147

TEVA PHARMACEUTICAL INDUSTRIES LIMITED

(TEVA)
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensus 
Quotes 5-day view   Delayed Quote. Delayed Tel Aviv Stock Exchange
05/20/2019 05/21/2019 05/22/2019 05/23/2019 05/26/2019 Date
4114(c) 4277(c) 4204(c) 4076(c) 3974(c) Last
695 571 549 131 504 401 672 389 561 311 Volume
+0.34% +3.96% -1.71% -3.04% -2.50% Change
More quotes
Company
Teva Pharmaceutical Industries Limited is a pharmaceutical company. The Company is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines. The Company operates through two segments: Generic medicines and Specialty medicines. The Company develops,... 
Sector
Pharmaceuticals
Calendar
-
More about the company
Latest news on TEVA PHARMACEUTICAL INDUST
10:37pJOHNSON & JOHNSON : Teva Pharmaceuticals to pay $85 mn to Oklahoma to settle opi..
AQ
12:56pJOHNSON & JOHNSON : Teva settles with Oklahoma for $85 million in opioid case
AQ
10:35aTEVA PHARMACEUTICAL INDUSTRIES : Settles Oklahoma Opioid Case for $85 Million --..
DJ
10:31aCOMPANY STATEMENT : Teva Reaches Agreement with State of Oklahoma to Resolve Sta..
BU
10:24aTEVA PHARMACEUTICAL INDUSTRIES : Settles Oklahoma Opioid Case for $85 Million
DJ
05/13Teva and Apple fall while Newmont Goldcorp and NextEra rise
AQ
05/13TEVA PHARMACEUTICAL INDUSTRIES : Down Over 14%, on Pace for Lowest Close Since N..
DJ
05/13GLOBAL MARKETS LIVE : EssilorLuxottica, Nissan, Euronext, Uber…
05/13TEVA PHARMACEUTICAL INDUSTRIES : finance chief denies price fixing plot
AQ
05/12TEVA PHARMACEUTICAL INDUSTRIES : Price-fixing lawsuit deals another blow to alre..
AQ
More news
Analyst Recommendations on TEVA PHARMACEUTICAL INDUST
More recommendations
Sector news : Pharmaceuticals - NEC
05/24NOVARTIS : At $2 Million, New Novartis Drug Is Priciest Ever
DJ
05/24NOVARTIS : Correction to Novartis Article
DJ
05/24NOVARTIS : FDA Approves Novartis' Piqray for Breast Cancer
DJ
05/24NOVARTIS' : Zolgensma Approved for Sale in U.S. to Treat SMA in Infants at $2.12..
DJ
05/24SAMSUNG ELECTRONICS : South Korea orders further arrests at Samsung Electronics ..
RE
More sector news : Pharmaceuticals - NEC
Chart TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Duration : Period :
Teva Pharmaceutical Industries Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TEVA PHARMACEUTICAL INDUST
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price 22,0 $
Spread / Average Target 94%
Managers
NameTitle
Kåre Schultz President, Chief Executive Officer & Director
Sol J. Barer Chairman
Carlo de Notaristefani Executive Vice President-Global Operations
Michael McClellan Chief Financial Officer & Executive Vice President
Amir Elstein Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
TEVA PHARMACEUTICAL INDUSTRIES LIMITED-30.50%12 345
JOHNSON & JOHNSON8.32%368 655
PFIZER-3.96%233 239
ROCHE HOLDING LTD.11.42%233 096
NOVARTIS17.44%219 832
MERCK AND COMPANY6.23%208 984